Parkview Logansport Hospital, INC.
Parkview Logansport Hospital, INC. was paid $9.76M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
LOGANSPORT, IN 46947
Next to other General Acute Care Hospital providers in Indiana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,624 | $748K | |
| 2019 | 34,127 | $1.38M | |
| 2020 | 25,195 | $1.02M | |
| 2021 | 28,866 | $1.48M | |
| 2022 | 37,515 | $2.00M | |
| 2023 | 40,692 | $2.07M | |
| 2024incomplete | 23,753 | $1.07M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 74,541 | 59,241 | $3.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 42,995 | 35,182 | $2.44M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.8% | 8,655 | 7,102 | $661K |
| 59425 | 5.3% | 9,507 | 6,580 | $514K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.3% | 4,884 | 4,405 | $415K |
| 59426 | 3.8% | 6,736 | 3,190 | $373K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 6,362 | 5,438 | $329K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.2% | 3,967 | 3,476 | $312K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 1,709 | 1,563 | $148K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.2% | 2,877 | 1,826 | $116K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.2% | 2,921 | 2,134 | $114K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 2,632 | 2,337 | $106K |
88 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,867 | $77K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,054 | $63K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 614 | $54K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 946 | $50K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,506 | $48K |
| 99205 | Prolong outpt/office vis | <1% | 439 | $47K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,258 | $46K |
| 95886 | <1% | 642 | $45K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,742 | $39K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 455 | $38K |
| 11721 | <1% | 3,705 | $36K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,156 | $33K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 575 | $31K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,080 | $29K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 925 | $28K |
| 20610 | <1% | 1,037 | $25K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,600 | $23K |
| 31575 | <1% | 363 | $21K | |
| 76830 | Ultrasound, transvaginal | <1% | 417 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 776 | $20K |
| 99460 | <1% | 326 | $18K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 448 | $17K |
| 17110 | <1% | 305 | $16K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,032 | $15K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 289 | $15K |
| 95913 | <1% | 119 | $13K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 242 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 289 | $10K |
| 59025 | Fetal non-stress test | <1% | 645 | $9K |
| 92567 | <1% | 1,181 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,825 | $8K |
| 31231 | <1% | 63 | $8K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 116 | $7K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 578 | $6K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 89 | $6K |
| 95937 | <1% | 226 | $5K | |
| 81025 | <1% | 1,038 | $5K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 132 | $5K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 210 | $5K |
| V5266 | Battery for use in hearing device | <1% | 224 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 714 | $4K |
| 97161 | <1% | 66 | $4K | |
| 11102 | <1% | 111 | $4K | |
| 99406 | <1% | 328 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 239 | $4K |
| 90715 | <1% | 164 | $2K | |
| 96127 | <1% | 877 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 50 | $2K |
| 11750 | <1% | 21 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 104 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 313 | $2K |
| 94726 | <1% | 293 | $2K | |
| 69210 | <1% | 88 | $2K | |
| 99381 | <1% | 31 | $1K | |
| 94729 | <1% | 312 | $1K | |
| 17000 | <1% | 65 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 90686 | <1% | 83 | $1K | |
| 76801 | <1% | 27 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 115 | $1K |
| 97165 | <1% | 13 | $1K | |
| 59430 | <1% | 90 | $1K | |
| 92553 | <1% | 38 | $993.77 | |
| 92557 | <1% | 52 | $953.14 | |
| 17004 | <1% | 18 | $876.92 | |
| 81003 | <1% | 827 | $814.07 | |
| 94060 | <1% | 135 | $749.89 | |
| 95812 | <1% | 42 | $731.71 | |
| 95819 | <1% | 18 | $707.47 | |
| 99307 | <1% | 242 | $653.21 | |
| 96161 | <1% | 453 | $603.73 | |
| 99462 | <1% | 20 | $519.86 | |
| 92587 | <1% | 37 | $504.43 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 54 | $463.68 |
| 99310 | Prolong nursin fac eval 15m | <1% | 20 | $389.96 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 23 | $331.39 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 58 | $326.06 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 340 | $298.64 |
| 73630 | <1% | 14 | $267.45 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $236.40 |
| 94010 | <1% | 32 | $138.26 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 23 | $73.55 |
| 81002 | <1% | 101 | $58.99 | |
| 99173 | <1% | 38 | $57.86 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 649 | $9.04 |
| 99385 | 0% | 13 | $0.00 | |
| 99318 | 0% | 55 | $0.00 | |
| 99305 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.